- Home
- IPSC vs BFIN Comparison
IPSC vs BFIN Comparison
Compare IPSC & BFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- BFIN
- Stock Information
- Founded
- IPSC 2019
- BFIN 1924
- Country
- IPSC United States
- BFIN United States
- Employees
- IPSC N/A
- BFIN N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- BFIN Savings Institutions
- Sector
- IPSC Health Care
- BFIN Finance
- Exchange
- IPSC Nasdaq
- BFIN Nasdaq
- Market Cap
- IPSC 49.6M
- BFIN 142.4M
- IPO Year
- IPSC 2021
- BFIN N/A
- Fundamental
- Price
- IPSC $0.54
- BFIN $11.53
- Analyst Decision
- IPSC Strong Buy
- BFIN
- Analyst Count
- IPSC 5
- BFIN 0
- Target Price
- IPSC $3.33
- BFIN N/A
- AVG Volume (30 Days)
- IPSC 1.2M
- BFIN 85.7K
- Earning Date
- IPSC 08-07-2025
- BFIN 07-30-2025
- Dividend Yield
- IPSC N/A
- BFIN 3.52%
- EPS Growth
- IPSC N/A
- BFIN N/A
- EPS
- IPSC N/A
- BFIN 0.36
- Revenue
- IPSC $114,898,000.00
- BFIN $48,547,000.00
- Revenue This Year
- IPSC $1,064.82
- BFIN $1.43
- Revenue Next Year
- IPSC N/A
- BFIN $4.33
- P/E Ratio
- IPSC N/A
- BFIN $31.88
- Revenue Growth
- IPSC 8286.72
- BFIN N/A
- 52 Week Low
- IPSC $0.34
- BFIN $10.01
- 52 Week High
- IPSC $3.29
- BFIN $13.97
- Technical
- Relative Strength Index (RSI)
- IPSC 48.22
- BFIN 41.00
- Support Level
- IPSC $0.55
- BFIN $11.32
- Resistance Level
- IPSC $0.60
- BFIN $11.71
- Average True Range (ATR)
- IPSC 0.04
- BFIN 0.28
- MACD
- IPSC -0.00
- BFIN -0.00
- Stochastic Oscillator
- IPSC 15.96
- BFIN 17.19
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About BFIN BankFinancial Corporation
BankFinancial Corp is a full-service, national bank providing banking, financial planning and fiduciary services to individuals, families and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, healthcare finance, equipment finance, commercial real estate finance and treasury management business customers. The Bank offers its customers a broad range of loan, deposit, trust and other financial products and services through approximately 18 full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through its Internet Branch.